pcp prevention studies
comparing atovaquone
inhaled pentamidine
patients
discontinued atovaquone
discontinued pentamidine
adverse events
rash
diarrhea
nausea
common reasons
discontinuing atovaquone
bronchospasm
common reason
discontinuing pentamidine
studies
comparing atovaquone
dapsone
treatment-limiting hypersensitivity reactions
dapsone group
treatment-limiting gastrointestinal side effects
atovaquone group
pcp treatment studies
patients
discontinued atovaquone
side effects
patients
receiving sulfamethoxazole-trimethoprim
common reason for discontinuation
treatment groups
atovaquone
sulfamethoxazole-trimethoprim
studies
comparing intravenous pentamidine
atovaquone
patients in the atovaquone group
patients in the pentamidine group
side effects
treatment
atovaquone patients
pentamidine patients
adverse events
common reasons
atovaquone group
hypoglycemia
vomiting in the pentamidine group
gastrointestinal side effects
nausea
diarrhea
vomiting
abdominal pain
oral monilia
taste perversion
constipation
incidence of side effects
patients in pcp treatment studies
prevention studies
percent of patients experience anorexia
patients experience dyspepsia
drug
serious underlying diseases in the patients
atovaquone
hyperamylasemia
patients
pancreatitis
postmarketing experience
dermatologic side effects
rash
pruritus
exfoliative dermatitis
photosensitivity
toxic epidermal necrolysis
erythema multiforme
stevens-johnson syndrome
skin desquamation
postmarketing experience in patients
receiving multiple drug treatment
atovaquone
hepatic side effects
elevated alt
times uln
elevated ast
times uln
elevated alkaline phosphatase
times uln
amylase
times uln
patients
pcp
therapy
patients
receiving atovaquone
alt/ast elevations
patients
sulfamethoxazole-trimethoprim
hepatomegaly
hepatitis
case of fatal liver failure
postmarketing experience
hematologic side effects
anemia
neutropenia
underlying disease
methemoglobinemia
thrombocytopenia
metabolic side effects
hyponatremia
hyperglycemia
hypoglycemia
other side effects
fever
asthenia
flu syndrome
pain
infection
sweating
malaise
underlying disease
fatigue
night sweats
burning sensation of the tongue
respiratory side effects
dyspnea
cough
rhinitis
sinusitis
bronchospasm
pneumonia
nervous system
side effects
insomnia
dizziness
headache
anxiety
depression
musculoskeletal side effects
myalgia
hypersensitivity reactions
rash
erythema multiforme
exfoliative dermatitis
allergic reactions
renal side effects
elevated creatinine
elevated bun
acute renal impairment
postmarketing experience
cardiovascular
side effects
hypotension
ocular side effects
vortex keratopathy
postmarketing experience
immunologic side effects
hypersensitivity reactions
angioedema
bronchospasm
throat tightness
urticaria
postmarketing experience
cough or hoarseness
breathing
fever or chills
side pain
difficult urination
tightness in the chest
black, tarry stools
bleeding gums
bloating
blood in the urine
stools
bluish-colored lips
fingernails
palms
constipation
dark urine
dizziness or lightheadedness
fast heartbeat
headache
indigestion
hive-like swelling on the face
eyelids
lips
tongue
throat
hands
legs
feet
sex organs
light-colored stools
loss of appetite
nausea
noisy breathing
pains in the stomach
side
abdomen
radiating
back
pale skin
red spots on the skin
rapid heart rate
sore throat
unusual bleeding
bruising
unusual tiredness
weakness
vomiting
yellow eyes
skin
stomach pain
diarrhea
lack
loss of strength
runny nose
skin rash
sneezing
sore mouth
tongue
stuffy nose
sweating
trouble sleeping
white patches in the mouth
tongue
throat
blistering
peeling
loosening of the skin
eye irritation
redness
itching
skin rash
muscle pain
red skin lesions
purple center